Clinipace Clinical Research

Clinipace was a private, full-service clinical research organization focused on outsourced clinical development services for biotechnology, pharmaceutical, and medical device companies. The company provided support across the clinical development continuum, including pre-IND strategy, trial execution, regulatory support, data management, and post-marketing surveillance. Clinipace built particular expertise in areas such as oncology, rare disease, nephrology, gastroenterology, and women’s health, and served emerging and mid-sized innovators seeking flexible CRO support. In April 2021, Clinipace merged with dMed Global, and the combined organization later rebranded to Caidya, with the Clinipace name officially retired as of November 15, 2022.